References
1.  Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies collaboration.
Age specific relevance of usual blood pressure to vascular mortality. A meta-analysis
of   individual data for a million adult in 61 prospective studies. Prospective studies
collaboration. The Lancet 2002; 360: 1903 - 13.
2.  Ruitenberg A, Skoog I, Ott A, Aevarsson O, Witteman, JC, Lernfelt B, et al. Blood
pressure and risk of dementia: result from the Rotterdam study and the Gothenberg
H-70 study. Dement Geriatric Cogn Disord 2001; 12: 33 - 9.
3.  Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk
Factors for Alzheimer’s disease and vascular dementia. Ann N Y Acad Sci 2000; 903:
411 - 23.
4.  B. Sabayan, L. W. Wijsman, J. C. Foster - Dingley et al. Association of visit-to-visit
variability in blood pressure with cognitive function in old age: prospective cohort study.
BMJ 2013; 347: f4600.
5. N. U. Epstein, K. A. Lane, and M. R. Farlow et al. Cognitive dysfunction and greater visit-
to-visit systolic blood pressure variability. Journal of the American Geriatrics Society
2013; 61(12): 2168 - 73.
6. M. Nagai, S. Hoshide, M. Nishikawa, S. Masahisa, and K. Kario. Visit-to-visit blood
pressure variability in the elderly: Associations with cognitive impairment and
carotid artery remodelling. Atherosclerosis 2014; 233(1): 19 - 26.
7. Jawed RA. Midlife hypertension is associated with impaired cognition and dementia
later. Clev Clin J Med 2002; 69: 664 - 9.
8. B. A. In’t Veld, A. Ruitenberg, A. Hofman, B. H. C. Stricker, M. M. B. Breteler. Anti-
hypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiology of
Aging 2001; 22(3): 407 - 12.
9.  P. J. Tully, J.F. Dartigues, S. Debette, C. Helmer, S. Artero, C. Tzourio. Dementia risk
with antihypertensive use and blood pressure variability. Neurology 2016; 87(6):
601 - 8.
10. S. Yasar, J. Xia, W. Yao et al. Antihypertensive drugs decrease risk of Alzheimer
disease: Ginkgo Evaluation of Memory Study. Neurology 2013; 81(10): 896 - 903.
11. R. Stewart, Q. Xue, K. Masaki et al. Change in Blood Pressure and Incident Dementia:
A 32-Year Prospective Study. Hypertension 2009; 54(2): 233 - 40.
12. B. Haring, C. Wu, L. H. Coker et al. Hypertension, Dietary Sodium and Cognitive decline:
Results from the Women’s Health Initiative Memory Study. American Journal of
Hypertension 2016; 29(2): 202 - 16.
13. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J,
Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC. 2014 evidence -
based guideline for the management of high blood pressure in adults: report from
the panel members appointed to the Eighth Joint National Committee (JNC 8).
JAMA 2014; 311(5): 507 - 20.
14. Forette F., Seux M.-L., Staessen J. A., et al. The prevention of dementia with anti -
hypertensive treatment: new evidence from the systolic hypertension in Europe (Syst -
Eur) study. Archives of Internal Medicine 2002; 162(18): 2046 - 52.
15. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H,
Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N. prevention
of Dementia by Antihypertensive Drugs: How AT1-receptor-blockers and Dihydro - pyridines Better Prevent Dementia in Hypertensive Patients than Thiazides and
ACE-inhibitors. Expert Rev Neurother 2009; 9(9): 1413 - 31. PMID: 19769454.
16. Jean K.Ho, Daniel A Nation & for the Alzheimer’s Disease Neuroimaging Initiative.
Memory is preserved in older adults taking AT1 receptor Blockers. Alzheimer’s
Research & Therapy 2017; 9: 33. DOI 10.1186/s13195-017-0255-9.
17. Bulpitt CJ, Fletcher AE. Cognitive function and angiotensin-converting enzyme
inhibitors in comparison with other antihypertensive drugs. J Cardiovasc Pharmacol
1992; 19(Suppl 6): S100 - 04.
18. Efimova IY, Efimova NY, Triss SV, Lishmanov YB. Brain perfusion and cognitive function
changes in hypertensive patients. Hypertens Res 2008; 31: 673 - 78.
19. Ekta Arora, Vijay Khajuria, Vishal R. Tandon, Atul Sharma, Naiyma Choudhary.
Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor
performance in healthy volunteers: A preliminary report. Perspectives in Clinical
Research 2014; 5(4): 190 - 94.
20. KavitaRathore, Sunil Kumar Mathur Comparative Study of two ARBs on Memory and
Psychomotor Functions in Mild to Moderate Hypertension. IJSR 2016; 5(9): 531 - 33.
21. Puram NN, Karande VB, Ramanand JB, Ramanand SJ, Halasawadekar NR, Bhosale RR.
Comparison of efficacy of telmisartan with losartan in patients of essential
hypertension with cognitive impairment. Int J Basic Clin Pharmacol 2016; 5: 702 - 6.
22. KavitaRathore, Sunil Kumar Mathur. Comparative Study of Telmisartan Alone and With
Atorvastatin On Cognitive Functions in Mild to Moderate Hypertensive Patients.
Indian Journal of Applied Research (IJAR) 2016; 6(9): 647 - 50.
23. C. Bachmeier, D. Beaulieu-Abdelahad, M. Mullan, D. Paris. Selective dihydropyiridine
compounds facilitate the clearance of beta-amyloid across the blood-brain barrier.
Eur. J. Pharmacol 2011; 659: 124 - 29.
24. S. Lesné, T. K. Ming, L. Kotilinek et al. A specific amyloid-β protein assembly in the
brain impairs memory. Nature 2006; 440 (7082): 352 - 357.
25. V Nimmrich, A Eckert. Calcium channel blockers and dementia. British Journal of
Pharmacology (BJP) 2013; 169: 1203 - 10.
26. Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F. New pharmacological
strategies for treatment of Alzheimer’s disease: focus on disease modifying drugs.
Br J Clin Pharmacol 2012; 73: 504 - 17.
27. Mukesh Madhukar Shete. Cilnidipine: Next Generation Calcium Channel Blocker.
J Assoc Physicians India 2016; 64(4): 95 - 99.
28. Pershad D, Wig NN. A battery of simple tests of memory for use in India. Neurol India
1976; 24: 86 - 93. [PubMed: 1012437]
29. Pershad D, Wig NN. Relationship between PGI Memory scale and WAIS verbal I.Q.
Neurol India 1979; 27: 69 - 72.
30. R Fogari, A Mugellini, A Zoppi, G Derosa, C Pasotti, E Fogari and P Preti. Influence of
losartan and atenolol on memory function in very elderly hypertensive patients.
Journal of Human Hypertension 2003; 17: 781 - 785.
31. Gore PN, Badar VA, Hardas MM, Bansode VJ, Navale SB. Comparative effects of
Telmisartan and Lisinopril on cognitive function in metabolic syndrome patients.
Int J Clin Exp Physiol 2014; 1: 216 - 20.
32. M Stuhec, J Keuschler, J Serra-Mestres, M Isetta. Effects of Different Antihypertensive
Medication Groups on Cognitive Function in Older Patients: A Systematic Review.
Eur Psychiatry 2017; 46: 1 - 15.
33.  Ashok Jaiswal, V. Bhavsar, Jaykaran, N. D. Kantharia. Effect of antihypertensive
therapy on cognitive functions of patients with hypertension. Ann Indian Acad
Neurol 2010; 13(3): 180 - 183.
Tables